Almstead Neil Gregory bought PTCT
July 6, 2026 · Form 4 insider transaction
Almstead Neil Gregory bought 811 shares of PTC Therapeutics, Inc. at $38.10 per share, a transaction worth $30.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
811
Price
$38.10
Total value
$30.9K
InsiderAlmstead Neil Gregory
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 6, 2026
Filing dateJuly 8, 2026
Shares owned after61,110
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.; Includes 162 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2026.